British Biosimilars Association

Trending Articles

  1. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  2. ISCC 15-18 October 2024 | Conference | Milan, Italy
  3. Rousselot Rousselot is the global leader* of collagen-based solutions for the food, health and nutrition, biomedical and pharmaceutical sectors. Working in partnership with our global...
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. PROFINET enables the seamless integration of Watson-Marlow pumps into Kühner single-use bioreactors A PROFINET interface has enabled the seamless integration of Watson-Marlow 630PnN/R and 730PnN/R pumps into the Siemens environment of Adolf Kühner AG’s SB2500-Z orbital...

Upcoming event

Boston Biotech Week

23-26 September, 2024 | Convention and exhibition | Boston, US See all

Related Content

Media

Life Science Industry Coalition position paper released

The associations representing the European and British life science industry (AESGP, ABPI, BIA, BGMA, EBE, EFPIA, EUCOPE, EuropaBio, Medicines for Europe, PAGB, Vaccines Europe) have launched a joint policy document on the potential impact of the UK’s exit from the EU
Manufacturing

British Biosimilars Association appoints new chair Kavya Gopal

You need to be a subscriber to read this article.
Click here to find out more.
Drug Delivery

Biosimilars: access through education

Biological medicines are playing a significant role on a global scale in providing effective treatments for patients and contributing to improved survival rates, as well as providing a better quality of life
Subscribe now